IPHA

Innate Pharma S.A. ADS (IPHA)

About Innate Pharma S.A. ADS (IPHA)

Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Hervé Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié, and François Romagné on September 23, 1999 and is headquartered in Marseille, France.

Details

Daily high

$2.07

Daily low

$2.00

Price at open

$2.02

52 Week High

$3.15

52 Week Low

$1.81

Market cap

167.6M

Dividend yield

0.00%

Volume

6,719

Avg. volume

9,575

P/E ratio

-4.55

Innate Pharma S.A. ADS News